Posted in | News | Quantum Physics

Ultra-Low Temperature Experiments on Superfluid Helium Propose Existence of Heavier Higgs Bosons

Researchers from the Aalto University, Finland, have revealed that Higgs particles are a lot heavier than suggested at the Large Hadron Collider in CERN in 2012.

Helium-3 experimental cell and extract of data showing creation of light Higgs mode (analog of 125 GeV Higgs boson). Illustration: Dr. Vladislav Zavyalov, Low Temperature Laboratory, Aalto University.

A recent study has suggested that more more Higgs particles can be found by studying superfluid helium.

From the proposed observation of the Higgs boson reported in 2012 at the Large Hadron Collider in CERN, it was observed that the mass of 125 GeV looks lighter than the anticipated energy scale of 1 TeV.

The researchers at Aalto University suggest that there are multiple Higgs boson, and that they're a lot heavier than originally observed. The latest results have been published in Nature Communications.

Our recent ultra-low temperature experiments on superfluid helium (3He) suggest an explanation why the Higgs boson observed at CERN appears to be too light.  By using the superfluid helium analogy, we have predicted that there should be other Higgs bosons, which are much heavier (about 1 TeV) than previously observed.

Professor (emeritus) Grigory E. Professor Volovik

Professor Volovik received the Onsager Prize in 2014 and the international Simon Prize in 2004 for his research in theoretical statistical physics, and in theoretical low temperature physics. Professor Volovik holds a position in Landau Institute, Moscow, and the Low Temperature Laboratory at Aalto University.

Recent CERN experiments have provided evidence that the second Higgs exist at the suggested region, at 0.75 TeV. This evidence has been the subject of widespread discussion and comment, with various papers submitted to arXiv. arXiv is an e-print service widely used by the physics community to circulate manuscripts of all their unpublished studies.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.